Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01327183 · ClinicalTrials.gov registry record · Phase 2
A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
A Phase 2 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 2
- Development phase
- 532
- Enrollment target
NCT01327183 is a Phase 2 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 532 participants.
The verdict
NCT01327183, a Phase 2 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 532 participants
- Enrollment target
Study Summary
This randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of RO4905417 in patients with non ST-elevation myocardial infarction (Non-STEMI) undergoing percutaneous coronary intervention (PCI). Patients will be randomized to receive an intravenous infusion of either 5 mg/kg RO4905417 or 20 mg/kg RO4905417 or placebo before PCI. Follow-up will be for 4 months.
Interventions
- DRUG placebo
- PROCEDURE Percutaneous Coronary Intervention (PCI)
- DRUG RO4905417
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 532 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01327183
The ClinicalTrials.gov registry entry for NCT01327183 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 532 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01327183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01327183 about?
NCT01327183 is a clinical study titled "A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention". This randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of RO4905417 in patients with non ST-elevation myocardial infarction (Non-STEMI) undergoing percutaneous coronary intervention (PCI). Patients will be randomized to receive an intravenous infusion of either...
What is the current status of trial NCT01327183?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 532 participants. The study started on 2011-05. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01327183?
The interventions under investigation include: placebo (DRUG), Percutaneous Coronary Intervention (PCI) (PROCEDURE), RO4905417 (DRUG).
Who is sponsoring clinical trial NCT01327183?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.